1
Genetic Study of CYP2D6 Enzyme and Therapeutic Drug Monitoring of Tamoxifen
Condition(s):Breast CancerLast Updated:July 8, 2019Unknown status
Tamoxifen: 549 Clinical Trials, Page 1 of 55
Hide Studies Not Open or Pending
2
Tamoxifen in Patients With Oesophageal Cancer
Condition(s):Cancer; Gastrointestinal NeoplasmsLast Updated:May 9, 2017Unknown status
3
Tamoxifen for Well Differentiated Neurodendocrine Tumors and Hormone Receptor Positive Expression
Condition(s):Neuroendocrine Tumors; Progesterone Receptor Positive Tumor; Estrogen Receptor Positive TumorLast Updated:January 5, 2021Recruiting
4
Tamoxifen Dose Adjustment on Indonesian Female ER+ Breast Cancer Patients Based on CYP2D6 Genotype and Endoxifen Levels
Condition(s):ER+ Breast CancerLast Updated:March 18, 2020Recruiting
5
Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression
Condition(s):Neuroendocrine Tumors; Progesterone Receptor Positive Tumor; Estrogen Receptor Positive TumorLast Updated:January 19, 2021Recruiting
6
Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)
Condition(s):Menorrhagia; Metrorrhagia; Medicated Intrauterine DevicesLast Updated:June 4, 2019Completed
7
Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors
Condition(s):Bladder CancerLast Updated:January 13, 2021Completed
8
Karolinska Interventional Study of Mammograhic Density (Karisma-1)
Condition(s):Breast Cancer; Mammographic DensityLast Updated:September 9, 2019Completed
9
Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer
Condition(s):Hormone Receptor Positive Malignant Neoplasm of Breast; Human Epidermal Growth Factor 2 Negative Carcinoma of Breast; Estrogen Receptor Positive Breast Cancer; Progesterone Receptor Positive Tumor; Metastatic Breast CancerLast Updated:July 29, 2020Active, not recruiting
10
TAK-228 Plus Tamoxifen in Patients With ER-Positive, HER2-negative Breast Cancer
Condition(s):Estrogen Receptor Positive Breast CancerLast Updated:April 16, 2019Completed